Advertisement
Guidelines and Guidance

Guidelines and Guidance The Guidelines and Guidance section contains advice on conducting and reporting medical research.

See all article types »

Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement

  • A. Cecile J. W. Janssens mail,

    a.janssens@erasmusmc.nl

    Affiliation: Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands

    X
  • John P. A. Ioannidis,

    Affiliations: Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece, Biomedical Research Institute, Foundation for Research and Technology, Ioannina, Greece, Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America, Center for Genetic Epidemiology and Modeling and Tufts CTSI, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, United States of America, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, United States of America

    X
  • Cornelia M. van Duijn,

    Affiliation: Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands

    X
  • Julian Little,

    Affiliation: Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada

    X
  • Muin J. Khoury,

    Affiliation: Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • for the GRIPS Group

    Membership of the GRIPS Group is provided in the Acknowledgments.

    X
  • Published: March 15, 2011
  • DOI: 10.1371/journal.pmed.1000420

About the Authors

A. Cecile J. W. Janssens, Cornelia M. van Duijn
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands
John P. A. Ioannidis
Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
John P. A. Ioannidis
Biomedical Research Institute, Foundation for Research and Technology, Ioannina, Greece
John P. A. Ioannidis
Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America
John P. A. Ioannidis
Center for Genetic Epidemiology and Modeling and Tufts CTSI, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, United States of America
John P. A. Ioannidis
Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, United States of America
Julian Little
Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada
Muin J. Khoury
Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

Corresponding Author

Email: a.janssens@erasmusmc.nl

Competing Interests

John P. A. Ioannidis is a member of the PLoS Medicine Editorial Board.

Author Contributions

ICMJE criteria for authorship read and met: ACJWJ JPAI CMvD JL MK. Agree with the manuscript's results and conclusions: ACJWJ JPAI CMvD JL MK. Designed the experiments/the study: ACJWJ JPAI CMvD MK. Wrote the first draft of the paper: ACJWJ. Contributed to the writing of the paper: ACJWJ JPAI CMvD JL MK. Contributed to preparation of workshop (organization of agenda, supporting text), provided input based on experience in developing STREGA statement: JL. Spearheaded the GRIPS effort and convened participants of the workshop at CDC: MJK.